A Phase III, Multi-centre, Double-blind, Randomised, Placebo-controlled Multiple Fixed-dose Study of MCI-196 Versus Placebo in Chronic Kidney Disease Stage V Subjects on Dialysis With Hyperphosphatemia and Dyslipidaemia (Incorporating Two Parallel High Dose Groups)
Phase of Trial: Phase III
Latest Information Update: 12 Nov 2014
At a glance
- Drugs Colestilan (Primary)
- Indications Dyslipidaemias; Hyperphosphataemia; Renal failure
- Focus Therapeutic Use
- Sponsors Mitsubishi Tanabe Pharma Corporation
- 27 Jun 2010 Actual patient number (642) added as reported by ClinicalTrials.gov.
- 16 Dec 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 12 Aug 2009 Additional trial location (Malaysia) identified as reported by ClinicalTrials.gov.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History